Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability

BACKGROUND: Astragaloside IV (AS-IV) has been shown to prevent ischemia-induced acute kidney injury (AKI) in rat models of ischemia and reperfusion. However, the effects of AS-IV on AKI during sepsis and endotoxinemia is unclear. The current study aimed to investigate the effects and molecular mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wei, Chen, Yi, Zhang, Xingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374805/
https://www.ncbi.nlm.nih.gov/pubmed/28328867
http://dx.doi.org/10.12659/MSM.899618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374805/
https://www.ncbi.nlm.nih.gov/pubmed/28328867
http://dx.doi.org/10.12659/MSM.899618

Ejemplares similares